Related Experiment Videos
The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues
Abstract:
The pyrogenic efect of the synthetic adjuvant N-acetylmuramyl-L-alanine-D-isoglutamine, also known as muramyl dipeptide (MDP), was studied in rabbits. MDP induced biphasic fevers in rabbits, but two structural analogues, N-acetylmuramyl-L-alanine-D-glutamic acid (MDPA) and the dimethylester of MDPA, were 10 times less pyrogenic. This finding was supported by studies in which MDP and its analogues released leukocytic pyrogen (LP) from rabbit phagocytic cells in vitro. In addition, MDP released LP from human phagocytes. Human phagocytes, however, required a 10-fold greater concentration of MDP than did rabbit cells. The structural analogues were similarly less effective than the parent molecule in releasing LP from human cells. All preparations of MDP were negative in the limulus amebocyte lysate test and failed to show pyrogenic cross-tolerance with bacterial endotoxin. Thus MDP, which is a pyrogenic molecule, is also able to release LP from rabbit phagocytes and to a lesser degree from human phagocytes, but does not cause gelation of limulus amebocyte lysate.
Insights
Muramyl dipeptide (MDP) causes fever in rabbits and releases pyrogenic substances from immune cells. Structural analogues of MDP are less pyrogenic and less effective at releasing pyrogen.
Area of Science:
- Immunology
- Pharmacology
Background:
- Synthetic adjuvants like muramyl dipeptide (MDP) are investigated for their biological effects.
- Understanding the pyrogenic properties of MDP and its analogues is crucial for drug development.
Purpose of the Study:
- To investigate the pyrogenic effects of muramyl dipeptide (MDP) and its structural analogues in rabbits.
- To determine the ability of MDP and its analogues to release leukocytic pyrogen (LP) from phagocytic cells.
Main Methods:
- Administering MDP and its analogues to rabbits to observe fever responses.
- In vitro studies using rabbit and human phagocytic cells to measure LP release upon exposure to MDP and analogues.
- Limulus amebocyte lysate (LAL) test to assess endotoxin-like activity.
Main Results:
- MDP induced biphasic fevers in rabbits; analogues were 10 times less pyrogenic.
- MDP released leukocytic pyrogen (LP) from rabbit and human phagocytes in vitro.
- Human phagocytes required 10-fold higher MDP concentrations than rabbit cells for LP release.
- Analogues were less effective than MDP in releasing LP from human cells.
- MDP and analogues tested negative in the LAL test and did not show cross-tolerance with bacterial endotoxin.
Conclusions:
- MDP is a pyrogenic molecule that stimulates LP release from phagocytes.
- The pyrogenicity and LP-releasing capacity of MDP are structure-dependent.
- MDP's pyrogenic mechanism differs from that of bacterial endotoxins.